Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Cannabist Company Holdings ( (TSE:CBST) ) is now available.
The Cannabist Company said an ad hoc group of holders of its 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes, both due December 31, 2028, has agreed to further extend a forbearance arrangement. The noteholders will refrain from exercising their rights and remedies under the governing indenture and applicable law until March 6, 2026, giving the cannabis operator additional time to manage its capital structure and negotiate with creditors.
The extension of forbearance provides short-term breathing room as The Cannabist Company navigates its debt obligations, which are significant for a sector still constrained by federal prohibition and limited banking access. The added time may help stabilize operations and preserve value for stakeholders while the company evaluates strategic and financial options in a challenging U.S. cannabis financing environment.
The most recent analyst rating on (TSE:CBST) stock is a Hold with a C$0.55 price target. To see the full list of analyst forecasts on Cannabist Company Holdings stock, see the TSE:CBST Stock Forecast page.
Spark’s Take on TSE:CBST Stock
According to Spark, TipRanks’ AI Analyst, TSE:CBST is a Underperform.
Cannabist Company Holdings is facing severe financial difficulties, with declining revenues, high leverage, and negative equity. The technical analysis indicates an overbought condition without clear momentum, and the valuation reflects unprofitability. These factors contribute to a low overall stock score.
To see Spark’s full report on TSE:CBST stock, click here.
More about Cannabist Company Holdings
The Cannabist Company, formerly Columbia Care, is a U.S. multi-state cannabis operator with licenses in 11 jurisdictions. It runs 69 facilities, including 54 dispensaries and 15 cultivation and manufacturing sites, serving both medical and adult-use markets with branded products across flower, edibles, oils and tablets.
Technical Sentiment Signal: Sell
Current Market Cap: C$227.8M
For a thorough assessment of CBST stock, go to TipRanks’ Stock Analysis page.